For fifty years, Washington’s war on marijuana failed to stop use, but it did succeed in strangling honest medical research that could help American families.
Story Snapshot
- Federal “Schedule I” rules barely dented marijuana use but made serious medical research almost impossible.
- Health and Human Services now says marijuana has real medical use and should be moved to Schedule III.
- President Trump’s executive order orders the Justice Department to speed up rescheduling and expand research.
- The Drug Enforcement Administration is holding a tightly controlled rescheduling hearing after years of blocking change.
How Prohibition Failed On Use But Crushed Research
For decades, federal law has treated marijuana the same as heroin and lysergic acid diethylamide, calling it a “Schedule I” drug with high abuse risk and no accepted medical use.[3] That label came with the toughest rules for scientists, including special licenses, narrow supply, and long approval delays, which many researchers simply could not overcome.[3] At the same time, large national surveys show millions of Americans continued to use cannabis despite this strict status.[7] Prohibition did not stop use; it only guaranteed we knew less about real risks, safe doses, and medical benefits.
Researchers and public health experts have warned for years that this lack of hard evidence is itself a public health problem.[3] Doctors were left with stories instead of data, while lawmakers were forced to guess at policy instead of relying on careful trials.[3] Serious reviews have now agreed that federal barriers, especially Schedule I rules and the old government monopoly on research-grade cannabis, created a “catch-22”: the Drug Enforcement Administration said there was not enough proof of medical value, while blocking the very studies that could provide that proof.[12]
What Has Changed Under Trump: Rescheduling And Research
In August 2023, the Department of Health and Human Services completed a formal scientific review and recommended that marijuana be moved from Schedule I to Schedule III because it has accepted medical uses and lower abuse risk than the most dangerous drugs.[2] That review cited strong support for cannabis to treat pain, chemotherapy-related nausea and vomiting, and loss of appetite in serious illness.[18] In May 2024, the Drug Enforcement Administration proposed a rule to follow that advice and reschedule marijuana, a huge shift after decades of refusal.[1]
Schedule III status still keeps marijuana as a controlled substance, but it reduces red tape for research, cuts the tax penalty that hits legal medical businesses, and finally admits under federal law that cannabis has medical value.[1][18] Analysts note that rescheduling will not legalize recreational use, allow interstate shipment, or erase all federal-state conflict, but it will “materially reduce tax burdens” by lifting the Section 280E tax rule and will “modestly ease research constraints.”[16] For patients and honest scientists, that is a real win, even if it is only a first step toward a more rational system.
Trump’s Order Versus Bureaucratic Drag At The DEA
After the Biden-era review stalled in endless hearings and delays, President Donald Trump signed a December 18 executive order telling the Attorney General to finish the job and move marijuana from Schedule I to Schedule III “in the most expeditious manner” allowed by law.[16][18] The Justice Department then issued an order placing Food and Drug Administration–approved marijuana medicines and state-licensed medical marijuana products into Schedule III right away and launched an expedited process to cover all marijuana.[21] Acting Attorney General Todd Blanche said this action aims to open the door to more research on safety and effectiveness, so doctors and patients can make better choices.[21]
"A Drug Enforcement Administration (DEA) judge has issued an order laying out the schedule for a hearing on the Trump administration’s move to reschedule cannabis that is set to start next week."#Marijuana #Cannabis #DEA #Rescheduling #Hearing #Schedule https://t.co/Tvt8kd54qd
— Omni Medical Services (@omnimedicalmmj) June 25, 2026
Yet the Drug Enforcement Administration has not fully changed its mindset. When it set a new hearing for June 29, 2026, on broader rescheduling, the agency denied participation requests from major reform groups like the National Organization for the Reform of Marijuana Laws and chose to hear only from organizations that want to keep marijuana in Schedule I.[4] That decision mirrors a long history in which the Drug Enforcement Administration has overruled its own administrative judges and ignored decades of cannabis research to preserve the old prohibition model.[14][15] The result is a process that looks more like a defense of bureaucratic power than a fair search for truth.
Why This Fight Matters To Conservative Readers
For many in our audience, this debate is not about getting high; it is about honest science, states’ rights, and federal overreach. Experts have found that moving cannabis from Schedule I to Schedule III would “significantly enhance research opportunities” because the new category carries fewer restrictions and allows more realistic studies of the products people actually use.[20] At the same time, rescheduling alone does not legalize recreational use, does not end drug-free workplace policies, and does not open interstate commerce, so it does not force any state to change its own standards.[18]
There is also a strong medical freedom angle. A comprehensive review by the National Academies and other research bodies has recognized that cannabis has at least some acceptable medical uses, especially for chronic pain and certain cancer-related symptoms.[20] When the federal government blocks research and denies that reality, it keeps suffering patients from low-cost options and pushes families toward more dangerous drugs, including opioids. Trump’s push to clear research roadblocks and to align federal policy with what many states have already seen on the ground moves the ball toward a system that respects evidence, local control, and personal responsibility instead of fear-based control from Washington.
Sources:
[1] Web – Prohibition Didn’t Stop Marijuana Use. It Stopped Marijuana Research.
[2] Web – DEA Selects Only Those Opposed to Rescheduling for Hearing
[3] Web – Federal Marijuana Rescheduling: Process and Impact
[4] Web – Prohibition Didn’t Stop Marijuana Use. It Stopped Marijuana Research.
[7] Web – 517
[12] Web – Evidence Suggests the DEA Still Resists Rescheduling Marijuana
[14] Web – Public Attitudes Toward the Drug Enforcement … – PMC
[15] Web – Report Suggests The DEA Has Ignored Four Decades Of Cannabis …
[16] Web – Here’s Why the DEA Will Never Reschedule Cannabis
[18] Web – Cannabis Rescheduling Explained | Vicente LLP
[20] YouTube – The Law, Policy, and Politics of Rescheduling Cannabis
[21] Web – Effects of the Federal Government’s Move to Reschedule Cannabis
